Copper peptides can degrade when exposed to unfavorable pH environments, excessive oxygen exposure, or incompatible ingredients
So then why doesnt another big pharmaceutical company swoop in, buy the patent, and use their exhaustive funds to get BPC FDA approved, then make billions of dollars selling the drug to an already interested market
Reported concerns include local injection reactions, potential immunogenicity from copper exposure with chronic use, and theoretical risks if peptides activate unintended growth pathways
For AOD 9604, the fasted morning window is more strictly important due to the insulin interaction that can blunt the lipolytic effect
CrossRef All references open in new window
Synergistic Integration Together, these three peptides address the complete regeneration cascade: initial response and inflammation control (BPC-157), cellular migration and reorganization (TB-500), and extracellular matrix synthesis and maturation (GHK-Cu)